Interferon gamma responses to myelin peptides in multiple sclerosis correlate with a new clinical measure of disease progression.
Moldovan IR, Rudick RA, Cotleur AC, Born SE, Lee JC, Karafa MT, Pelfrey CM. Interferon gamma responses to myelin peptides in multiple sclerosis correlate with a new clinical measure of disease progression. J Neuroimmunol. 2003 Aug; 141(1-2):132-40.